A-17.5 mg A-17.5 mg Pill - yellow capsule/oblong, 14mm

Generic Name: acitretin

Pill with imprint A-17.5 mg A-17.5 mg is Yellow, Capsule/Oblong and has been identified as Soriatane 17.5 mg. It is supplied by GlaxoSmithKline.

Soriatane is used in the treatment of Psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Soriatane 17.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A-17.5 mg A-17.5 mg

Soriatane

Generic Name: acitretin
Imprint: A-17.5 mg A-17.5 mg
Strength: 17.5 mg
Color: Yellow
Size: 14.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Antipsoriatics
Pregnancy Category: X - Not for use in pregnancy
CSA Schedule: Not a controlled drug
Labeler / Supplier: GlaxoSmithKline
National Drug Code (NDC): 00145-3817 (Discontinued)
Inactive Ingredients: microcrystalline cellulose, sodium ascorbate, gelatin, maltodextrin, ferric oxide yellow, ferrosoferric oxide, ferric oxide red, titanium dioxide
Note: Inactive ingredients may vary.